Open-label Study With Bosentan in Interstitial Lung Disease

Mise à jour : Il y a 4 ans
Référence : NCT00319033

Femme et Homme

Extrait

This study will asses the long term safety and efficacy of oral bosentan to patients suffering from Interstitial Lung Disease.


Critère d'inclusion

  • interstitial lung disease ,Scleroderma


Liens